NN, Inc. (NASDAQ: NNBR) – Q2 2026 Earnings
Press release and earnings call link
Section 1: Main Takeaways
NN, Inc. is a diversified precision-manufacturing company that makes engineered metal components and assemblies. Historically, the business was more heavily tied to automotive, but management is deliberately shifting toward higher-growth and higher-margin end markets, especially AI/data-center infrastructure, defense/electronics, and robotic surgery/medical. Automotive has now fallen to roughly 40% of the business, while the three targeted growth markets together exceed $150 million of sales and roughly one-third of the company.
The financial trajectory is clearly improving: Q2 sales rose 19% year over year to $128.7 million, adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) rose 36% to $17.9 million, and adjusted EBITDA margin expanded 170 basis points to 13.9%. The press release established the turnaround story, but the call materially strengthened it by showing that many of the largest new awards contributed essentially nothing to first-half results and are only beginning to ramp, while management is already discussing a longer-term adjusted EBITDA margin target of roughly 14%-16%.
Quarterly Results
Earnings Release Date: Aug. 5, 2026
Stock Price: $3.85
Market Cap: $193.4 million
Q2 2026 sales of $128.7 million vs $107.9 million in the prior year
Q2 2026 Non-GAAP Adjusted EPS of $0.11 vs $0.02 in the prior year
Q2 2026 GAAP Diluted EPS of $(0.13) vs $(0.26) in the prior year
Quick Takeaway
NN, Inc. is moving from a turnaround phase into an aggressive growth-and-capacity-expansion phase, led by Data Center/liquid cooling, Defense and Medical. The most interesting feature of the Q2 call is that several major new programs were not yet contributing to first-half results, while management sees Data Center sales ramping materially beginning around November and believes longer-term adjusted EBITDA margins can reach 14%-16%.
The opportunity is substantial, but so are the execution requirements: NN needs large amounts of new equipment and factory space, must complete another step in its debt refinancing, and has already experienced significant common-share dilution.
Press Release vs Call Transcript Comparison
The most important shift in the call is that management framed NN less as a turnaround industrial manufacturer and more as a company moving into a capacity-expansion phase. The press release already showed accelerating sales and margins, but the call provided evidence that current financial results do not yet reflect many of the highest-profile program wins.
The growth is also becoming increasingly diversified. Data Center receives most of the attention, but Defense already represents approximately $60 million of trailing revenue with a $90 million near-term goal, while Medical sits near $15 million with a $40 million target. This diversification reduces the risk that the entire growth thesis depends on one end market.
The key investor tension is therefore straightforward: operating momentum appears to be accelerating at exactly the same time that NN must fund a large physical expansion and complete its balance-sheet cleanup. If management executes both, the business could look substantially different by 2027; if capacity or financing becomes constrained, some of today’s program wins may take longer to convert into earnings.
Investor Underappreciation Signals
✅ Major wins have barely reached reported revenue — NN said the large Data Center, Medical and Defense awards provided essentially no first-half benefit, meaning the strong Q2 results preceded several important ramps that start in the second half.
✅ November Data Center inflection — Management expects the first 50-machine Data Center ramp to exceed $1 million of monthly sales around November and continue increasing into Q1 2027, a level of timing detail absent from the press release.
✅ Capacity planning implies substantially more demand — The release discusses 50 new machines, but the call says NN is already evaluating enough additional factory space for roughly 200 more machines, suggesting management sees a much larger opportunity set.
✅ New business is structurally more profitable — Management said new wins still carry roughly five percentage points higher gross margins than NN’s existing portfolio, so changing revenue mix could drive earnings faster than sales.
✅ Reported margins contain a hidden inflation drag — Precious-metal pass-through revenue adds sales but little profit, mechanically depressing percentage margins, yet adjusted EBITDA margin still expanded 170 basis points in Q2.
✅ Medical could double before becoming noticeable in consolidated results — The newly awarded robotic-surgery work could approximately double NN’s current Medical business, but Medical remains small enough that the opportunity can be missed when investors focus on consolidated revenue.
✅ Guidance contains explicit conservatism — Management acknowledged that guidance is somewhat conservative because normal Q4 seasonality is being weighed against unusually large new-product ramps, creating potential upside if launches stay on schedule.
✅ Financing savings could become another earnings catalyst — Retiring preferred securities is expected to reduce annual paid-in-kind financing expense by roughly $13 million, while management is already pursuing a second refinancing step for the term loan.
Section 2: Supplementary Information
Positive Insights
Negative Insights
Tariff Risk
Tariffs were discussed specifically in relation to steel. Management said NN experiences inflation across its major metals and tracks steel tariffs and other surcharges closely through its procurement organization.
The principal mitigation mechanism is contractual cost pass-through. NN says it can demonstrate increases in input costs to customers and true-up the resulting cost changes, seeking full recovery. Management emphasized that it does not try to profit from these increases but attempts not to lose money either.
Therefore, the transcript suggests the biggest tariff/inflation effect is presently working capital and reported margin percentages, rather than an outright earnings hit. Elevated pass-through revenue increases the denominator of margin calculations without adding much profit.
Management did not indicate that tariffs are currently causing:
lost customers;
material market-share erosion;
relocation of production;
reduced innovation;
major sourcing changes;
expected material earnings deterioration.
The company did acknowledge that tariffs and surcharges are a “moving target.” Accordingly, the primary risk would be an inability to recover increases quickly enough or a working-capital squeeze if metal costs continue rising rapidly.
Hot Stock Trends Analysis
Previous Earnings Call
Quarter-over-quarter comparison (Previous Analysis)
Q1 2026: Management framed the quarter as continued proof that NN’s turnaround was working, with cost reductions, better sales mix, and diversification into Data Center/electric grid, Defense, and Medical driving improved results. The company raised 2026 guidance and accelerated its long-term targets, but several growth initiatives were still early, especially Medical, while the preferred-stock refinancing remained unresolved.Q2 2026: The tone became much more confident as the story shifted from turnaround to capacity-driven growth, with Data Center, Defense, and Medical all showing stronger traction and many new wins still not contributing to first-half results. Management completed the $89 million preferred-stock refinancing, raised its long-term adjusted EBITDA margin view to 14%-16%, and outlined major second-half production ramps, but also introduced new risks around dilution, capital needs, and execution across more than 150 programs in ramp-up mode.
Year-over-year comparison
Q2 2025: Management was constructive but cautious, with the focus still on restructuring, margin improvement, portfolio cleanup, and offsetting weak automotive and macro conditions through new business wins. Guidance was maintained but skewed toward the lower end, while preferred-stock refinancing, additional growth investments, and possible M&A were still works in progress.
Q2 2026: The tone became much more confident and growth-oriented, with sales up 19%, adjusted EBITDA up 36%, higher guidance, and the preferred-stock refinancing completed. Data Center, Defense, and Medical had become much more important growth drivers, with major new programs still ramping and Data Center requiring significant additional equipment and space; the story had shifted from fixing the business to funding and executing a faster expansion phase.